Bacteria News and Research

RSS

Researchers develop new way to detect hidden urinary tract infections

Researchers in infection biology have developed a new way to detect hidden urinary tract infections. The research was led by Professor Agneta Richter-Dahlfors, head of the Swedish Medical Nanoscience Center at Karolinska Institutet and published in NPJ Biofilms and Microbiomes.

26 Oct 2018

King's researchers analyze potential risks of C-section

A series of papers published in the Lancet shows that globally the number of babies born through cesarean section (C-section) almost doubled between 2000 and 2015: from 12% to 21% of all births or nearly 30 million worldwide.

26 Oct 2018

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.

26 Oct 2018

Gene that makes some people susceptible to middle ear infections identified

Researchers at the University of Colorado Anschutz Medical Campus have found multiple genetic variants within the FUT2 gene that makes some people especially susceptible to middle ear infections.

25 Oct 2018

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

A study funded by Diabetes UK has found that treating periodontitis (gum disease) could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications.

25 Oct 2018

Researchers use neutrons to explore complex outer surfaces of E.coli

Researchers have been using neutrons to explore the complex outer surfaces of the bacterium Escherichia coli, and they have revealed in the process, with great precision and detail, how such bacteria interact with their surroundings.

25 Oct 2018

Researchers track where tetracycline antibiotics go in human cells

We know that antibiotics treat bacterial infections. We also know why they work. Tetracycline antibiotics, for example, stop bacteria from making protein. Like a boot on a wheel, the drugs bind to the bacterial cell's ribosome--where protein is made--and prevent it from working. Without protein, the bacteria weaken and die.

25 Oct 2018

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

New tool may shed light on how to grow replacement tissues and organs for implants

From "Fantastic Voyage" to "Despicable Me," shrink rays have been a science-fiction staple on screen. Now chemists at The University of Texas at Austin have developed a real shrink ray that can change the size and shape of a block of gel-like material while human or bacterial cells grow on it.

24 Oct 2018

Researchers engineer new 'smart' repellent surface coatings

Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions.

24 Oct 2018

New vaccine strategy shows promise to protect chickens against serious respiratory disease

A new vaccine strategy could offer protection to millions of chickens threatened by a serious respiratory disease, research shows.

23 Oct 2018

Innovative computer software sheds new light on genetic processes underlying deadly diseases

Innovative computer software developed by University of Leicester scientists is shedding new light on the genetic makeup of deadly pathogens responsible for meningitis and gastroenteritis.

23 Oct 2018

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

The trillions of bacteria in the human gut affect our health in multiple ways including effects on immune functions and metabolism.

23 Oct 2018

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.

23 Oct 2018

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder.

23 Oct 2018

New approach may lead to better diagnostic techniques for autoimmune disorders

If we really want to know how our body's cells work - or don't work, in the case of disease - we might need to look beyond their genes and even beyond the proteins they are made of.

23 Oct 2018

Innovative strategy opens up new avenue of treatment for anthrax infections

A team led by Professor Arne Skerra at the Technical University of Munich has developed an innovative strategy for preventing the anthrax bacterium from absorbing iron, which is crucial for its survival.

22 Oct 2018

Researchers discover how acne-causing bacteria resist treatment

Researchers in Sweden have discovered how acne-causing bacteria feed off their human hosts. The study, which was performed at KTH Royal Institute of Technology, could make it possible to find effective ways to treat severe acne.

22 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

Using FLUOstar Omega to study new gut bacteria that can influence our health

The Microbial Biology and Metagenomics group at the University of Queensland’s Diamantina Institute uses the BMG LABTECH FLUOstar Omega microplate reader to develop new methods to study the human gut microbiome.

From BMG LABTECH GmbH 19 Oct 2018

Bacteria News and Research

Researchers develop new way to detect hidden urinary tract infections

King's researchers analyze potential risks of C-section

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Gene that makes some people susceptible to middle ear infections identified

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

Researchers use neutrons to explore complex outer surfaces of E.coli

Researchers track where tetracycline antibiotics go in human cells

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

New tool may shed light on how to grow replacement tissues and organs for implants

Researchers engineer new 'smart' repellent surface coatings

New vaccine strategy shows promise to protect chickens against serious respiratory disease

Innovative computer software sheds new light on genetic processes underlying deadly diseases

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

New approach may lead to better diagnostic techniques for autoimmune disorders

Innovative strategy opens up new avenue of treatment for anthrax infections

Researchers discover how acne-causing bacteria resist treatment

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Using FLUOstar Omega to study new gut bacteria that can influence our health

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo